Bio/Pharma News

Jun 22, 2018
By Pharmaceutical Technology Editors
The three-year collaboration will focus on developing vaccines for up to five infectious disease pathogens.
Jun 22, 2018
By Pharmaceutical Technology Editors
The approval is intended to increase patient access to treatment for opioid addiction.
Jun 20, 2018
By Pharmaceutical Technology Editors
The acquisition is expected to strengthen Roche’s personalized healthcare strategy.
Jun 20, 2018
By Pharmaceutical Technology Editors
The acquisition is expected to strengthen Sanofi’s R&D strategy with Ablynx’s nanobody technology platform.
Jun 20, 2018
By Pharmaceutical Technology Editors
The company has resubmitted a biologics license application to FDA for its proposed biosimilar to Roche’s Herceptin.
Jun 19, 2018
By Pharmaceutical Technology Editors
Johnson & Johnson has accepted an offer from Platinum Equity to acquire diabetes solutions business LifeScan for $2.1 billion.
Jun 13, 2018
By Pharmaceutical Technology Editors
Alexion Pharmaceuticals and Complement Pharma will partner to develop a preclinical C6 complement inhibitor to treat neurodegenerative disorders.
Jun 13, 2018
By Pharmaceutical Technology Editors
WuXi Biologics will invest $60 million to establish a biologics production facility in Massachusetts.
Jun 13, 2018
By Pharmaceutical Technology Editors
The companies will partner in research for HIV and hepatitis B immunotherapies, and Hookipa will manufacture arenavirus-based vectors for clinical development by Gilead.
Jun 13, 2018
By Pharmaceutical Technology Editors
Bayer completed its acquisition of Monsanto, the largest in Bayer’s history.
native1_300x100
lorem ipsum